Adrenocortical Carcinoma

• FDA label_change · 2024-01-09
  FDA Approved: LYSODREN — Supplemental Application (ESTEVE PHARMACEUTICALS, S.A.)

  FDA approved a supplemental application for LYSODREN (mitotane) submitted by Esteve Pharmaceuticals, resulting in changes to the product lab…

• FDA label_change · 2016-03-11
  FDA Approved: LYSODREN — Supplemental Application (ESTEVE PHARMACEUTICALS, S.A.)

  FDA approved a supplemental application for LYSODREN (mitotane) submitted by ESTEVE Pharmaceuticals, S.A.